Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism

被引:164
作者
Bourdeau, I
Bard, C
Noël, B
Leclerc, I
Cordeau, MP
Bélair, M
Lesage, J
Lafontaine, L
Lacroix, A
机构
[1] CHUM, Hotel Dieu, Dept Diagnost Radiol, Div Endocrinol, Montreal, PQ H2W 1T8, Canada
[2] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ H2W 1T8, Canada
关键词
D O I
10.1210/jc.87.5.1949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic exposure to excess glucocorticoids results in cognitive and psychological impairment. A few studies have indicated that cerebral atrophy can be found in patients with Cushing's syndrome (CS), but its evolution after cure has not been studied extensively. We report the presence of apparent cerebral atrophy in CS and its reversibility after the correction of hypercortisolism. Thirty-eight patients with CS, including 21 with Cushing's disease and 17 with adrenal CS were studied. The control groups consisted of IS patients with other non-ACTH-secreting sellar tumors and 20 normal controls. Twenty-two patients with CS were reevaluated after cure. Subjective loss of brain volume was present in 86% of patients with Cushing's disease and 100% of patients with adrenal CS. The values for third ventricle diameter, bicaudate diameter, and subjective evaluation were significantly increased in CS groups in comparison with the control group (P less than or equal to 0.001). Imaging reevaluated at 39.7 +/- 34.1 months after achieving eucortisolism showed an improvement of the third ventricle diameter (P = 0.001), bicaudate diameter (P < 0.0005), and subjective evaluation (P = 0.05). We conclude that brain volume loss is highly prevalent in CS and is at least partially reversible following correction of hypercortisolism.
引用
收藏
页码:1949 / 1954
页数:6
相关论文
共 40 条
  • [11] Cognitive decline in patients with Cushing's syndrome
    Forget, H
    Lacroix, A
    Somma, M
    Cohen, H
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2000, 6 (01) : 20 - 29
  • [12] DECREASED CEREBRAL GLUCOSE-METABOLISM IN PATIENTS WITH BRAIN-TUMORS - AN EFFECT OF CORTICOSTEROIDS
    FULHAM, MJ
    BRUNETTI, A
    ALOJ, L
    RAMAN, R
    DWYER, AJ
    DICHIRO, G
    [J]. JOURNAL OF NEUROSURGERY, 1995, 83 (04) : 657 - 664
  • [13] HAWRYLYSHYN P A, 1976, Applied Neurophysiology, V39, P34
  • [14] REVERSIBILITY OF CEREBRAL ATROPHY IN ANOREXIA-NERVOSA AND CUSHINGS-SYNDROME
    HEINZ, ER
    MARTINEZ, J
    HAENGGELI, A
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1977, 1 (04) : 415 - 418
  • [15] HORNER HC, 1990, NEUROENDOCRINOLOGY, V52, P57
  • [16] Huber G, 1982, Rofo, V137, P42, DOI 10.1055/s-2008-1056156
  • [17] Recovery of the brain choline level in treated Cushing's patients as monitored by proton magnetic resonance spectroscopy
    Khiat, A
    Bard, C
    Lacroix, A
    Boulanger, Y
    [J]. BRAIN RESEARCH, 2000, 862 (1-2) : 301 - 307
  • [18] Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome.
    Lacroix, A
    Hamet, P
    Boutin, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) : 1577 - 1581
  • [19] Cortisol levels during human aging predict hippocampal atrophy and memory deficits
    Lupien, SJ
    de Leon, M
    de Santi, S
    Convit, A
    Tarshish, C
    Thakur, M
    McEwen, BS
    Hauger, RL
    Meaney, MJ
    [J]. NATURE NEUROSCIENCE, 1998, 1 (01) : 69 - 73
  • [20] CEREBRAL, ATROPHY AND PLASMA-CORTISOL LEVELS IN ALCOHOLICS AFTER SHORT OR A LONG-PERIOD OF ABSTINENCE
    MARCHESI, C
    DERISIO, C
    CAMPANINI, G
    PIAZZA, P
    GRASSI, M
    CHIODERA, P
    VESCOVI, PP
    COIRO, V
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (03) : 519 - 535